How Exercise Can Help Neuropathy

0

SOG_1888_13-2For many patients treated with chemotherapy, peripheral neuropathy can be an uncomfortable and sometimes dangerous side effect. The condition, which includes tingling or loss of sensation in the arms or legs, can increase risk for falls and fall-related injuries.

To help prevent and ease these problems, Dana-Farber exercise physiologist Nancy Campbell, MS, recommends patients use low-impact exercise routines like finger taps, calf stretches, and ankle rolls. These exercises help increase blood flow to the peripheral nerves, restoring feeling in the extremities. The routines also build strength and improve balance, which can lead to fewer falls.

View Campbell’s presentation below for more information on how exercise may help ease or prevent neuropathy, including step-by-step instructions for helpful exercises:

Comments Sort By Newest

Leave a Reply

Your email address will not be published. Required fields are marked *

Blue Captcha Image
Refresh

*

Latest Tweets

Dana-Farber @danafarber
Is No Treatment the Best Treatment for DCIS #BreastCancer? https://t.co/8sRwXAycQR #bcsm https://t.co/AiRV3HQRkl
Dana-Farber @danafarber
What Is the Difference Between Hodgkin #Lymphoma and Non-Hodgkin Lymphoma? [Infographic] https://t.co/8D8CEtpxDf https://t.co/91KxtKCvqD
Dana-Farber @danafarber
RT @exercise_cancer: Did u know u can access @DanaFarber Zakim Center's movement class schedule from home? Just click on calendar tab. htt…

Make An Appointment

For adults: 877-442-3324

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.